# Commission Delegated Regulation (EU) No 877/2013 of 27 June 2013 supplementing Regulation (EU) No 473/2013 of the European Parliament and of the Council on common provisions for monitoring and assessing draft budgetary plans and ensuring the correction of excessive deficit of the Member States in the euro area, Annex II

Extent: E+W+S+N.I.

Table to be transmitted quarterly
Costs related to the COVID-19 pandemic
The last year of the availability period or of a possible disbursement of the Pandemic Crisis Support (whichever is earlier) is also the last year of the reporting, unless the Member State has not yet used all the funds drawn.
Items and sub-items, as necessary, accompanied with the relevant explanations to allow the Commission to perform a meaningful assessment.
This can include, inter alia, spending on hospitals; cure and rehabilitative care, ambulatory cure and rehabilitative care, diagnostics, pharmaceuticals, preventive care, health administrations, and health related long-term care.
Year 2020
Year 2021
In EUR million Time series of actual data ending at quarter of the respective report to be submitted
Q1
Q2
Q3
Q4
Q1
Q2
Q3
Q4
Healthcare, cure and prevention costs directly related to the COVID-19 pandemic
[Item]
[Further items as necessary]
Part of overall public healthcare spending estimated to be directly or indirectly attributed to addressing the impact of COVID-19 on the healthcare system
[Item]
[Further items as necessary]
Other indirect costs related to healthcare, cure and prevention due to the COVID-19 crisis
[Item]
[Further items as necessary]

---
Source: https://www.legislation.gov.uk/eur/2013/877/annex/II (the official version)
Page: https://openlegislation.uk/eu-regulation-2013-877/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.